JPH03123765A - Production of 4-amino-3-hydroxypentanoic acid derivative - Google Patents
Production of 4-amino-3-hydroxypentanoic acid derivativeInfo
- Publication number
- JPH03123765A JPH03123765A JP1259992A JP25999289A JPH03123765A JP H03123765 A JPH03123765 A JP H03123765A JP 1259992 A JP1259992 A JP 1259992A JP 25999289 A JP25999289 A JP 25999289A JP H03123765 A JPH03123765 A JP H03123765A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- amino
- group
- general formula
- aminopropanal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- KYYLCNHXZCPNBW-UHFFFAOYSA-N 4-amino-3-hydroxypentanoic acid Chemical class CC(N)C(O)CC(O)=O KYYLCNHXZCPNBW-UHFFFAOYSA-N 0.000 title claims description 9
- QPMCUNAXNMSGTK-UHFFFAOYSA-N 2-aminopropanal Chemical class CC(N)C=O QPMCUNAXNMSGTK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002841 Lewis acid Substances 0.000 claims abstract description 9
- 150000007517 lewis acids Chemical class 0.000 claims abstract description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims 3
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical class CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 claims 1
- LGVJIYCMHMKTPB-UHFFFAOYSA-N 3-hydroxynorvaline Chemical class CCC(O)C(N)C(O)=O LGVJIYCMHMKTPB-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract description 24
- -1 ketene silyl acetal Chemical class 0.000 abstract description 22
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 abstract description 12
- 239000002904 solvent Substances 0.000 abstract description 12
- 150000001875 compounds Chemical class 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 125000003277 amino group Chemical group 0.000 abstract description 4
- 125000006239 protecting group Chemical group 0.000 abstract description 3
- 239000011968 lewis acid catalyst Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Substances CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- QPMCUNAXNMSGTK-VKHMYHEASA-N (2s)-2-aminopropanal Chemical class C[C@H](N)C=O QPMCUNAXNMSGTK-VKHMYHEASA-N 0.000 description 5
- BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical group CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZOFRRNUENOHELM-LURJTMIESA-N (2s)-2-amino-4-methylpentanal Chemical class CC(C)C[C@H](N)C=O ZOFRRNUENOHELM-LURJTMIESA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 230000006340 racemization Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 4
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XPWWRSIBXKFKTA-QMMMGPOBSA-N (2s)-2-(cyclohexylamino)propan-1-ol Chemical class OC[C@H](C)NC1CCCCC1 XPWWRSIBXKFKTA-QMMMGPOBSA-N 0.000 description 2
- PTQLETOZAXDLEP-QMMMGPOBSA-N (2s)-2-(cyclohexylamino)propanal Chemical class O=C[C@H](C)NC1CCCCC1 PTQLETOZAXDLEP-QMMMGPOBSA-N 0.000 description 2
- VPSSPAXIFBTOHY-LURJTMIESA-N (2s)-2-amino-4-methylpentan-1-ol Chemical class CC(C)C[C@H](N)CO VPSSPAXIFBTOHY-LURJTMIESA-N 0.000 description 2
- BPSNETAIJADFTO-UHFFFAOYSA-N 2-pyridinylacetic acid Chemical compound OC(=O)CC1=CC=CC=N1 BPSNETAIJADFTO-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- VXTFXHNHEYHXKY-NSHDSACASA-N C[C@@H](C=O)N(C1CCCCC1)C(=O)OC(C)C Chemical compound C[C@@H](C=O)N(C1CCCCC1)C(=O)OC(C)C VXTFXHNHEYHXKY-NSHDSACASA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101000579218 Homo sapiens Renin Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 2
- 235000008206 alpha-amino acids Nutrition 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- QVDXUKJJGUSGLS-LURJTMIESA-N methyl L-leucinate Chemical compound COC(=O)[C@@H](N)CC(C)C QVDXUKJJGUSGLS-LURJTMIESA-N 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- KYYLCNHXZCPNBW-IMJSIDKUSA-N (3S,4S)-4-amino-3-hydroxypentanoic acid Chemical class C[C@H](N)[C@@H](O)CC(O)=O KYYLCNHXZCPNBW-IMJSIDKUSA-N 0.000 description 1
- UQWNNUPJBDWRHC-UWVGGRQHSA-N (3s,4s)-4-amino-5-cyclohexyl-3-hydroxypentanoic acid Chemical class OC(=O)C[C@H](O)[C@@H](N)CC1CCCCC1 UQWNNUPJBDWRHC-UWVGGRQHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- CDCHBOQVXIGZHA-UHFFFAOYSA-N 1,2-dihydropyrrol-5-one Chemical class O=C1NCC=C1 CDCHBOQVXIGZHA-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KLHXNCKWUKQVLR-UHFFFAOYSA-N 1-aminopentan-3-one Chemical compound CCC(=O)CCN KLHXNCKWUKQVLR-UHFFFAOYSA-N 0.000 description 1
- JPGZDACJIPHKML-UHFFFAOYSA-N 2-aminopentan-3-ol Chemical compound CCC(O)C(C)N JPGZDACJIPHKML-UHFFFAOYSA-N 0.000 description 1
- LTVRSJBNXLZFGT-UHFFFAOYSA-N 2-silylethenone Chemical compound [SiH3]C=C=O LTVRSJBNXLZFGT-UHFFFAOYSA-N 0.000 description 1
- WDGCBNTXZHJTHJ-UHFFFAOYSA-N 2h-1,3-oxazol-2-id-4-one Chemical class O=C1CO[C-]=N1 WDGCBNTXZHJTHJ-UHFFFAOYSA-N 0.000 description 1
- PCXDJQZLDDHMGX-UHFFFAOYSA-N 3-aminopropanal Chemical class NCCC=O PCXDJQZLDDHMGX-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- RUXKKCPQQQDJGN-NSHDSACASA-N C(C)(C)OC(=O)N([C@@H](C)CO)C1CCCCC1 Chemical compound C(C)(C)OC(=O)N([C@@H](C)CO)C1CCCCC1 RUXKKCPQQQDJGN-NSHDSACASA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001315609 Pittosporum crassifolium Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- ROBXZHNBBCHEIQ-UHFFFAOYSA-N ethyl 2-aminopropanoate Chemical class CCOC(=O)C(C)N ROBXZHNBBCHEIQ-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002724 inhibitory effect on hypertension Effects 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical group OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 150000002560 ketene acetals Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- SWVMLNPDTIFDDY-FVGYRXGTSA-N methyl (2s)-2-amino-3-phenylpropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-FVGYRXGTSA-N 0.000 description 1
- YUWDBOLCDYSGAV-LBPRGKRZSA-N methyl (2s)-3-phenyl-2-(propan-2-yloxycarbonylamino)propanoate Chemical compound CC(C)OC(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 YUWDBOLCDYSGAV-LBPRGKRZSA-N 0.000 description 1
- DWKPPFQULDPWHX-UHFFFAOYSA-N methyl 2-aminopropanoate Chemical class COC(=O)C(C)N DWKPPFQULDPWHX-UHFFFAOYSA-N 0.000 description 1
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- LHTVMBMETNGEAN-UHFFFAOYSA-N pent-1-en-1-ol Chemical class CCCC=CO LHTVMBMETNGEAN-UHFFFAOYSA-N 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- DNAJDTIOMGISDS-UHFFFAOYSA-N prop-2-enylsilane Chemical compound [SiH3]CC=C DNAJDTIOMGISDS-UHFFFAOYSA-N 0.000 description 1
- QDQVXVRZVCTVHE-UHFFFAOYSA-N propan-2-yl 2-aminopropanoate Chemical class CC(C)OC(=O)C(C)N QDQVXVRZVCTVHE-UHFFFAOYSA-N 0.000 description 1
- JCYDDSKYFXQFFA-LBPRGKRZSA-N propan-2-yl N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]carbamate Chemical compound CC(C)OC(=O)N[C@H](CO)Cc1ccccc1 JCYDDSKYFXQFFA-LBPRGKRZSA-N 0.000 description 1
- ODRPJOTYDJJVCI-VIFPVBQESA-N propan-2-yl N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate Chemical compound C(C)(C)OC(=O)N[C@@H](CC(C)C)C=O ODRPJOTYDJJVCI-VIFPVBQESA-N 0.000 description 1
- AHIHJODVQGBOND-UHFFFAOYSA-M propan-2-yl carbonate Chemical compound CC(C)OC([O-])=O AHIHJODVQGBOND-UHFFFAOYSA-M 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- DUPBILVWMPJNKH-UHFFFAOYSA-N pyridine;sulfur dioxide Chemical compound O=S=O.C1=CC=NC=C1 DUPBILVWMPJNKH-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は一般式
4の直鎖もしくは分枝アルキル基または置換もしくは無
置換アリール基を表す)で表されるケテンシリルアセタ
ールとルイス酸存在下反応させることを特徴とする、一
般式
(式中、R1は炭素数1〜4の直鎖もしくは分枝アルキ
ル基、炭素数5〜8の置換もしくは無置換のシクロアル
キル基を表し、また、R富はアミノ基の保!!基を表す
)で表される2−アミノプロパナール誘導体を、一般式
(式中、R3、R4、R1,Rhは各々独立に、炭素数
1〜(式中、R1、R8およびR3は前記と同じ意味を
表す)で表される4−アミノ−3−ヒドロキシペンタン
酸誘導体の製造法に関する0本発明によれば、(S)−
配置を有する一般式(1)で表される2−アミノプロパ
ナール誘導体から、(33,4S)−配置を有する一般
式(f[[)で表される4−アミノ−3−ヒドロキシペ
ンタン酸誘導体を高立体選択的に製造することができ、
例えば、R1としてイソプロピル基またはシクロヘキシ
ル基を有する一般式(1)で表される(S)−2−アミ
ノプロパナール誘導体から、Illとしてイソプロピル
基またはシクロヘキシル基を有する一般式(II[)で
表される(33.43)−4−アミノ−3−ヒドロキシ
ペンタン酸誘導体を高立体選択的に製造することができ
る。Detailed Description of the Invention [Industrial Application Field] The present invention relates to a ketene silyl acetal represented by the general formula 4 (representing a linear or branched alkyl group or a substituted or unsubstituted aryl group) in the presence of a Lewis acid. The general formula (wherein R1 represents a straight chain or branched alkyl group having 1 to 4 carbon atoms, a substituted or unsubstituted cycloalkyl group having 5 to 8 carbon atoms, and R A 2-aminopropanal derivative represented by the general formula (wherein R3, R4, R1, Rh each independently has a carbon number of 1 to (in the formula, According to the present invention, (S)-
From a 2-aminopropanal derivative represented by the general formula (1) having the configuration, to a 4-amino-3-hydroxypentanoic acid derivative represented by the general formula (f[[) having the (33,4S)-configuration can be produced with high stereoselectivity,
For example, from a (S)-2-aminopropanal derivative represented by the general formula (1) having an isopropyl group or a cyclohexyl group as R1, to a (S)-2-aminopropanal derivative represented by the general formula (II[) having an isopropyl group or a cyclohexyl group as Ill, (33.43)-4-amino-3-hydroxypentanoic acid derivatives can be produced with high stereoselectivity.
本発明によって製造される一般式(l[[)で表される
4−アミノ−3−ヒドロキシペンタン酸誘導体は、医薬
品の合成原料としての用途を有する。The 4-amino-3-hydroxypentanoic acid derivative represented by the general formula (l[[) produced by the present invention has uses as a raw material for the synthesis of pharmaceuticals.
例えば、一般式(III)において、R1がイソプロピ
ル基、3位不斉炭素が(S)−配置および4位不斉炭素
が(S)−配置である化合物は、ヒトレニン阻害作用に
より高血圧症治療剤として有用なペプチド様化合物の製
造中間体(J、Bogsr+et al、+^nnJe
p、in Med、Ches、+Academlc
Press、1985+Vo1.20.pp257−
226. J、Boger、et al、、J、M
ed、Chew、。For example, in the general formula (III), a compound in which R1 is an isopropyl group, the asymmetric carbon at the 3-position is an (S)-configuration, and the asymmetric carbon at the 4-position is an (S)-configuration is a therapeutic agent for hypertension due to its human renin inhibitory action. Intermediates for the production of peptidomimetic compounds useful as (J, Bogsr+et al, +^nnJe
p,in Med,Ches,+Academlc
Press, 1985+Vo1.20. pp257-
226. J., Boger, et al., J.M.
ed,Chew,.
2旦+1779(1985)、 R,Matiued
a、 eL al、、Ches+、Lstt、。2dan+1779 (1985), R,Matiued
a, eL al,, Ches+, Lstt,.
1985.1041.M、G、Bock、et al
、、J、Med、Chem、、31.1918(198
8)、に、l1zuka、at al、+Ches、
Pharm、Bull。 1旦。1985.1041. M.G.Bock et al.
,,J,Med,Chem,, 31.1918 (198
8), ni, l1zuka, at al, +Ches,
Pharm, Bull. 1st.
2278(1988)、特開昭61−236770.特
開昭64−26596゜特開平1−143898.特開
平1−143899)として用いられる。また、一般式
(1)において、R1がシクロヘキシル基、3位不斉炭
素が(S)−配置および4位不斉炭素が(S)−配置で
ある化合物は、より強力なヒトレニン阻害作用により高
血圧症治療剤として有用なペプチド様化合物の製造中間
体(J、Boger、at al、、J、Med、Ch
em、、28.1779(1985)、森沢ら、日本薬
学会第109年会、名古屋、1989年、講演要旨集I
Lp6.にJiwada、et al、+Hypert
enslon。2278 (1988), JP-A-61-236770. JP-A-64-26596° JP-A-1-143898. JP-A-1-143899). In addition, in the general formula (1), a compound in which R1 is a cyclohexyl group, the asymmetric carbon at the 3-position is an (S)-configuration, and the asymmetric carbon at the 4-position is an (S)-configuration, has a stronger human renin inhibitory effect on hypertension. Intermediates for the production of peptide-like compounds useful as therapeutic agents for diseases (J, Boger, at al., J. Med, Ch.
em, 28.1779 (1985), Morisawa et al., 109th Annual Meeting of the Pharmaceutical Society of Japan, Nagoya, 1989, Collection of Lecture Abstracts I
Lp6. Jiwada, et al, +Hypert
enslon.
■、70B(198B) 、特開昭62−33141.
特開昭64−26596)として使用できる。■, 70B (198B), JP-A-62-33141.
It can be used as JP-A-64-26596).
有用な医薬品の製造中間体である4−アミノ−3−ヒド
ロキシペンタン酸誘導体は、従来(1)(S)−α−ア
ミノ酸から合成した(S)−α−アミノプロパナール誘
導体へ酢酸エチルから偶製した金属エノラートを反応さ
せる方法(J、Bogeret al、、J、Med
、Chea、、 28.1779(1985)、D、
H,Rlch。4-Amino-3-hydroxypentanoic acid derivatives, which are intermediates in the production of useful pharmaceuticals, are conventionally synthesized from (1) (S)-α-amino acids to (S)-α-aminopropanal derivatives from ethyl acetate. Method for reacting prepared metal enolates (J, Bogere et al., J. Med.
, Chea, 28.1779 (1985), D.
H, Rlch.
et al、、J、 Org、Chea、、43.36
24(1978)、Wルlu et al、。et al., J. Org. Chea., 43.36
24 (1978), Wlu et al.
J、 Org、Chem、、43,754(197B
)、M、T、Reetz、et al、。J. Org. Chem., 43,754 (197B
), M.T., Reetz, et al.
Angew、Chea、Int、Ed、Engl、、2
5.1)41(1987)、) 。Angew, Chea, Int, Ed, Engl., 2
5.1) 41 (1987), ).
(21(S)−α−アミノ酸から合成した(S)−α−
アミノプロパナール誘導体に酢酸と光学活性アルコール
のエステルから調製したリチウムエノラートを反応させ
る方法(R,M、Devant、et al、+Tet
rahedron Lett、、29.2307(19
8B)、) (31(S)−α−アミノ酸から合成した
(S)−α−アミノプロパナール誘導体に光学活性3−
(メチルチオアセチル)−2−オキサゾリドン誘導体を
反応し、さらに脱硫反応を行う方法(J、5avrda
、5ynth、Commun、。((S)-α- synthesized from 21(S)-α-amino acids
A method of reacting an aminopropanal derivative with a lithium enolate prepared from an ester of acetic acid and an optically active alcohol (R, M, Devant, et al, +Tet
rahedron Lett,, 29.2307 (19
8B),) (31) Optically active 3-aminopropanal derivative synthesized from (S)-α-amino acid
A method of reacting (methylthioacetyl)-2-oxazolidone derivatives and further carrying out a desulfurization reaction (J, 5avrda
, 5ynth, Commun.
17、1901(19B?) 、) 、 +41 (S
)−α−アミノ酸から合成した(S)−α−アミノプ
ロパナール誘導体を光学活性ジオールと反応して光学活
性アセタール誘導体とし、このものをアリルシランで開
環する方法(W、S、Johnson、 et al、
、Tetrahedron Lett1堕、 6535
(1987)、)、 (51(S)−α−アミノ酸から
合成した(S)−α−アミノプロパナール誘導体と1.
3−ジメトキシ−1−トリメチルシリル−1,3−ブタ
ジェンとのDlels−Alder反応による方法(M
、M、Midland、et al、、J、A−、Ch
em、Sac、、旦L436B(1989)、)。17, 1901 (19B?) , ) , +41 (S
) -α-Aminopropanal derivative synthesized from α-amino acid is reacted with an optically active diol to obtain an optically active acetal derivative, which is then ring-opened with allylsilane (W, S, Johnson, et al. ,
, Tetrahedron Lett1 Fallen, 6535
(1987), ), (51 (S)-α-aminopropanal derivative synthesized from (S)-α-amino acid and 1.
Method by Dels-Alder reaction with 3-dimethoxy-1-trimethylsilyl-1,3-butadiene (M
,M,Midland,et al., ,J,A-,Ch.
em, Sac,, Dan L436B (1989), ).
+61(S)−α−アミノ酸から合成した(S)−4−
アミノ−3−オキソペンタン#I誘導体の3位カルボニ
ル基を還元する方法(R,Noyor14etrahe
dronLett、、29.6327(1988)、J
jouin、 et al、+J、org。(S)-4- synthesized from +61(S)-α-amino acid
Method for reducing the 3-position carbonyl group of amino-3-oxopentane #I derivative (R, Noyor14etrahe
droneLett, 29.6327 (1988), J
jouin, et al, +J, org.
Chea、、54,627(1989)、D、H,RI
ch、et al、、J、Org、Chem、。Chea, 54, 627 (1989), D.H.RI.
ch,et al,,J,Org,Chem,.
53.869(198B)、門、M、5chaldt、
et al、+Tetrahedron。53.869 (198B), Gate, M, 5chaldt,
et al, +Tetrahedron.
44.3489(1988)、P、F、5chuda、
at al、、Eur、Pat、Appl、。44.3489 (1988), P, F, 5chuda,
at al,, Eur, Pat, Appl.
0306143 A1.)、 (71(S ) −cx
−7ミノ酸から合成した(S)−4−アミノ−2(Z
)−ペンテン1−オール誘導体のエポキシ化による方法
(H,Kogen。0306143 A1. ), (71(S) -cx
(S)-4-amino-2(Z) synthesized from -7 amino acid
)-by epoxidation of penten-1-ol derivatives (H, Kogen.
at al、+ J、Chea、Soc、Ches
、Commun、、1987+3比)。at al, + J, Chea, Soc, Ches
, Commun, , 1987+3 ratio).
(81(S)−α−アミノ酸がら合成した光学活性2−
アミドアルコール誘導体の2−オキサゾリドン誘導体へ
の閉環反応による方法<S、Kano+et al、+
Tetrahedron Lett、+28.6331
(1987)、)、 +91 (S) −α−アミノ酸
から合成した光学活性ピロール−2(5H)−オン誘導
体の還元による方法(P、Jouln+et al、
、J、Ches、Soc、Perkin L 19
8ヱ、1)7?、)。(81(S)-Optically active 2- synthesized from α-amino acid
Method by ring-closing reaction of amide alcohol derivative to 2-oxazolidone derivative <S, Kano+et al, +
Tetrahedron Lett, +28.6331
(1987), ), +91 (S) Method by reduction of optically active pyrrol-2(5H)-one derivatives synthesized from -α-amino acids (P, Jouln+et al.
,J.,Ches,Soc.,Perkin L 19
8ヱ, 1) 7? ,).
αl光学活性2−オキソ−3−オキサプリン誘導体から
製造する方法(T、Kumeda、et al、+J、
org、ches、+53.3381(1988)、)
、Qll (R) −2,3−イソプロピリデングリセ
ルアルデヒド、1,2,5.6−ジー0−イソプロピリ
デン−D−グルコースなどのw誘導体から製造する方法
(MJinoshlta at al、。Method for producing αl from optically active 2-oxo-3-oxapurine derivatives (T, Kumeda, et al, +J,
org, chess, +53.3381 (1988),)
, Qll (R) -2,3-isopropylidene glyceraldehyde, a method for producing from w derivatives such as 1,2,5,6-di-0-isopropylidene-D-glucose (MJinoshlta at al.
Bull、Chew、Soc、Jpn、、 48,57
0(1975)、J、Mulzer、atal、、Li
ebigs Ann、Chem、、1988+445.
およびH,Yanagisawa+et al、+ch
em、Lett、+ 1989+687.)などによっ
て合成されていた。しかしながら、これらの製造法のう
ち(υの方法では3位水酸基の生成における立体選択性
あるいは反応の収率が低く、反応成績体の分離精製が大
きな障害であり、(2)、(3ン、(4ンの方法は(S
)−α−アミノ酸由来の不斉中心に加えて、いま一つの
不斉源を用いるので、経済性および不斉源の除去や回収
の点で工業的に実施するのは困難である。(5)−〇〇
の方法は、3位水酸基の生成における立体選択性は高い
ものの多段階を必要とする製造法であり、工業的に実施
するのは多大な困難が伴うものである。Bull, Chew, Soc, Jpn,, 48,57
0 (1975), J. Mulzer, atal, Li.
ebigs Ann, Chem, 1988+445.
and H, Yanagisawa+et al, +ch.
em, Lett, +1989+687. ) etc. were synthesized. However, among these production methods, the stereoselectivity or reaction yield in the production of the 3-position hydroxyl group is low, and the separation and purification of the reaction product is a major obstacle. (The fourth method is (S
In addition to the chiral center derived from )-α-amino acid, another chiral source is used, so it is difficult to implement it industrially in terms of economy and removal and recovery of the chiral source. Although the method (5)-〇〇 has high stereoselectivity in the production of the 3-position hydroxyl group, it is a production method that requires multiple steps, and it is very difficult to implement it industrially.
本発明者らは、医薬品製造中間体である前記−般式(I
ll)で表される4−アミノ−3〜ヒドロキシペンタン
酸誘導体を前記一般式(1)で表される2−アミノプロ
パナール誘導体から、(1)が有する唯一の不斉源を利
用して高立体選択的に効率良く製造する方法、すなわち
、(S)−配置を有する一般式(りで表される2−アミ
ノプロパナール誘導体から(3S、4S)−4−アミノ
−3−ヒドロキシペンタン酸誘導体を高立体選択的に効
率良く製造する方法を探索した結果、本発明の製造法を
見出し、本発明を完成した。The present inventors have discovered the above formula (I), which is an intermediate for pharmaceutical production.
The 4-amino-3-hydroxypentanoic acid derivative represented by ll) is synthesized from the 2-aminopropanal derivative represented by the general formula (1) using the only asymmetric source of (1). A method for stereoselectively and efficiently producing (3S,4S)-4-amino-3-hydroxypentanoic acid derivatives from 2-aminopropanal derivatives having the (S)-configuration represented by the general formula As a result of searching for a method to efficiently produce with high stereoselectivity, the production method of the present invention was discovered and the present invention was completed.
本発明に用いられる前記一般式(1)で表される2−ア
ミノプロパナール誘導体は下記の反応式に従い容易に製
造できる。The 2-aminopropanal derivative represented by the general formula (1) used in the present invention can be easily produced according to the following reaction formula.
(式中、「およびR諺は前記と同じ意味を表し、Rtは
炭素数1〜4の直鎖または分枝低級アルキル基を表す、
)
〔第1工程〕
本工程は、一般式(IV)で表される2−アミノプロピ
オン酸エステル誘導体に7ミノ基の保護基を導入後エス
テル基を還元し、さらに必要に応じて3位フェニル基な
どの還元を行い、一般式(V)で表される2−アミノ−
プロパツール誘導体を製造するものである(参考側参照
)。(In the formula, "and R represent the same meanings as above, Rt represents a straight chain or branched lower alkyl group having 1 to 4 carbon atoms,
) [First step] In this step, a 7-mino protecting group is introduced into the 2-aminopropionic acid ester derivative represented by the general formula (IV), and then the ester group is reduced, and if necessary, the 3-position phenyl 2-amino- represented by general formula (V) by reducing groups such as
This is to produce propatool derivatives (see reference side).
2−アミノプロピオン酸エステル誘導体としては、2−
アミノプロピオン酸メチル誘導体、2−アミノプロピオ
ン酸エチル誘導体、2−アミノプロピオン酸イソプロピ
ル誘導体などが例示でき、これらのものは公知の方法に
よって製造できる()1.5ekl at al、+c
hes+、Phar鱈、Bu1).+ 13+ 995
(1965)、、およびS、R,5andler an
d W、Karo+”Functional Grou
p Preparations”、Academic
Press+New York、1968.pP245
〜265.参照)。As the 2-aminopropionic acid ester derivative, 2-
Examples include methyl aminopropionate derivatives, ethyl 2-aminopropionate derivatives, and isopropyl 2-aminopropionate derivatives, which can be produced by known methods.
hes+, Phar cod, Bu1). +13+995
(1965), and S.R.
d W, Karo+”Functional Grou
p Preparations”, Academic
Press+New York, 1968. pP245
~265. reference).
2−アミノプロピオン酸エステル誘導体に導入されるア
ミノ基の保!!基としては、酸性条件下、加水分解する
ことによって除去できるものならばいかなるものも使用
できるが、好適にはホルミル基、アセチル基、プロピオ
ニル基、ブチリル基、イソブチリル基などの炭素数1〜
4の直鎖あるいは分枝アルカノイル基、ベンゾイル基、
p−クロロベンゾイル基、p−メトキシベンゾイル基な
どの無置換あるいは置換アロイル基、メトキシカルボニ
ル基、エトキシカルボニル基、イソプロポキシhルボニ
ル基、t−ブチルオキシカルボニル基などの炭素数1〜
5の直鎖あるいは分枝アルコキシカルボニル基、ベンジ
ルオキシカルボニル基、p−/)ロロベンジルオキシ力
ルボニル基、p−)トキシベンジルオキシ力ルボニル基
などの無置換あるいは置換アラルコキシカルボニル基が
用いられる。これらの保護基は公知の方法によって導入
できる(T、W、Greene、”Protectiv
e [;roups in OrganicSynth
esig”、John−Wlley & 5ons、N
ew York、1980゜pp218−287参照)
。Preservation of amino groups introduced into 2-aminopropionic acid ester derivatives! ! Any group can be used as long as it can be removed by hydrolysis under acidic conditions, but groups with 1 to 1 carbon atoms such as formyl group, acetyl group, propionyl group, butyryl group, and isobutyryl group are preferable.
4 straight chain or branched alkanoyl group, benzoyl group,
Unsubstituted or substituted aroyl groups such as p-chlorobenzoyl group and p-methoxybenzoyl group, methoxycarbonyl group, ethoxycarbonyl group, isopropoxy carbonyl group, and t-butyloxycarbonyl group having 1 to 1 carbon atoms
Unsubstituted or substituted aralkoxycarbonyl groups such as straight-chain or branched alkoxycarbonyl groups, benzyloxycarbonyl groups, p-/)lolobenzyloxycarbonyl groups, and p-)toxybenzyloxycarbonyl groups are used. . These protecting groups can be introduced by known methods (T., W. Greene, “Protective
e [;roups in OrganicSynth
esig”, John-Wllley & 5ons, N
ew York, 1980゜pp218-287)
.
アミノ基が保護された2−アミノプロピオン酸エステル
誘導体のエステル基の還元は、適当な還元剤、例えば塩
化リチウムまたは臭化リチウム存在下、水素化ホウ素ナ
トリウムを用いて行われる(参考側参照)。Reduction of the ester group of the 2-aminopropionic acid ester derivative in which the amino group is protected is carried out using sodium borohydride in the presence of a suitable reducing agent, such as lithium chloride or lithium bromide (see reference side).
なお、一般式(V)で表される2−アミノプロパツール
誘導体の3位にシクロヘキシル基が存在する化合物は、
対応する2−アミノ−3−フェニルプロパツール誘導体
の3位フェニル基を適当な触媒、例えば、5%ロジウム
−アルミナの存在下に水添することにより得ることもで
きる。In addition, the compound in which a cyclohexyl group is present at the 3-position of the 2-aminopropanol derivative represented by the general formula (V),
It can also be obtained by hydrogenating the 3-position phenyl group of the corresponding 2-amino-3-phenylpropatur derivative in the presence of a suitable catalyst, for example 5% rhodium-alumina.
本工程において、(S)−配置を有する一般式(TV)
で表される2−アミノプロピオン酸エステル誘導体を用
いた場合には、(S)−配置を有する一般式(V)で表
される2−アミノプロパツール誘導体をラセミ化するこ
となく得ることができる。In this step, the general formula (TV) having the (S)-configuration
When using the 2-aminopropionic acid ester derivative represented by, the 2-aminopropanol derivative represented by the general formula (V) having the (S)-configuration can be obtained without racemization. .
本工程において、一般式(IV)で表される2−アミノ
プロピオン酸エステル誘導体として(S)−ロイシンメ
チルエステルおよび(S)−フェニルアラニンメチルエ
ステルを用いた場合には、一般式(V)で表さる(S)
−ロイシノール誘導体および(S)−シクロへキシルア
ラニノール誘導体をラセミ化することなく得ることがで
きる(参考側参照)。In this step, when (S)-leucine methyl ester and (S)-phenylalanine methyl ester are used as the 2-aminopropionic acid ester derivatives represented by general formula (IV), Monkey (S)
-Leucinol derivatives and (S)-cyclohexylalaninol derivatives can be obtained without racemization (see reference side).
〔第2工程〕
本工程は、一般式(V)で表される2−アミノプロパツ
ール誘導体を酸化し、一般式(+)で表される2−アミ
ノプロパナール誘導体を製造するものである。好適な酸
化方法としては、ジメチルスルホキシド中二酸化イオウ
−ピリジン錯体−トリエチルアミンを用いる方法が例示
できる(参考側参照)。[Second Step] In this step, the 2-aminopropanal derivative represented by the general formula (V) is oxidized to produce the 2-aminopropanal derivative represented by the general formula (+). An example of a suitable oxidation method is a method using sulfur dioxide-pyridine complex-triethylamine in dimethyl sulfoxide (see reference side).
本工程において、(S)−配置を有する一般式(V)で
表される2−アミノプロパツール誘導体を用いた場合に
は、(S)−配置を有する一般式(1)で表される2−
アミノプロパナール誘導体をラセミ化することなく得る
ことができる。In this step, when using a 2-aminopropanol derivative represented by the general formula (V) having the (S)-configuration, 2-aminopropanol derivatives represented by the general formula (1) having the (S)-configuration −
Aminopropanal derivatives can be obtained without racemization.
本工程において、−i式(V)で表される2アミノプロ
パツ一ル誘導体として(S)−ロイシノール誘導体およ
び(S)−シクロへキシルアラニノール誘導体を用いた
場合には、一般式(+)で表される(S)−ロイシナー
ル誘導体および(S)−シクロへキシルアラニナール誘
導体をラセミ化することなく得ることができる(参考側
参照)。In this step, when (S)-leucinol derivatives and (S)-cyclohexylalaninol derivatives are used as the 2-aminopropanol derivatives represented by the -i formula (V), the general formula (+) The represented (S)-leucinal derivatives and (S)-cyclohexylalaninal derivatives can be obtained without racemization (see reference side).
上記の合成工程によって製造される一般式(1)で表さ
れる2−アミノプロパナール誘導体から本発明の下記の
製造法により、一般式(Ill)で表される4−アミノ
−3−ヒドロキシペンタン酸誘導体を高立体選択的に効
率よく製造することができる。4-Amino-3-hydroxypentane represented by general formula (Ill) is produced by the following production method of the present invention from the 2-aminopropanal derivative represented by general formula (1) produced by the above synthetic process. Acid derivatives can be efficiently produced with high stereoselectivity.
H (式中、171%R1、R1、R4 RゝおよびR−は前記と同 じ意味を表す)。H (In the formula, 171% R1, R1, R4 Rゝ and R- are the same as above. (represents the same meaning).
〔第3工程〕
−a式(II)で表されるケテンアセタールとしては、
0−メチル−〇−トリメチルシリルケテンアセタール、
0−エチル−〇−)リメチルシリルケテンアセタール、
0−メチル−〇−1−ブチルジメチルシリルケテンアセ
クール、0−エチル−〇−【−ブチルジメチルシリルケ
テンアセタール、0−メチル−〇−1−ブチルジフェニ
ルシリルケテンアセタール、0−1−ブチル−0−1−
ブチルジメチルシリルケテンアセクール、0−フェニル
−0−トリメチルシリルケテンアセタールなどが例示で
きるが、好適には、0−メチル−o−トリメチルシリル
ケテンアセタールが用いられる。[Third step] -a As the ketene acetal represented by formula (II),
0-methyl-〇-trimethylsilylketene acetal,
0-ethyl-〇-)limethylsilylketene acetal,
0-Methyl-〇-1-butyldimethylsilylketene acecool, 0-ethyl-〇-[-butyldimethylsilylketene acetal, 0-methyl-〇-1-butyldiphenylsilylketene acetal, 0-1-butyl-0 -1-
Examples include butyldimethylsilylketene acecool, 0-phenyl-0-trimethylsilylketene acetal, and preferably 0-methyl-o-trimethylsilylketene acetal.
用いられるシリルケテンアセタールは酢酸メチルから常
法に従い合成し、精製することなくそのまま反応に用い
ることができ、当量は2〜3当量用いて行う(H,W、
Rathke et al、+5ynth、Commu
n、、 3+67(1973)、 ) 、本反応には
ルイス酸の存在が必要であり、用いられるルイス酸とし
ては、四塩化チタン、三フッ化ホウ素・エーテル錯体、
四塩化スズ、塩化亜鉛、ヨウ化亜鉛、臭化マグネシウム
、トリス〔2,2−ビス(トリ重水素メチル)−1),
1−)り重水素−6,6,7,7,8,8゜8−へブタ
フルオロオクタンジオネイト−(3゜5)〕−ユーロピ
ウム(I[[)
(Eu(fad)s)などが例示される。ルイス酸は2
いられる。The silyl ketene acetal used is synthesized from methyl acetate according to a conventional method and can be used as it is in the reaction without purification.
Rathke et al, +5ynth, Commu
n, 3+67 (1973), ), this reaction requires the presence of a Lewis acid, and the Lewis acids used include titanium tetrachloride, boron trifluoride/ether complex,
tin tetrachloride, zinc chloride, zinc iodide, magnesium bromide, tris[2,2-bis(trideuteromethyl)-1),
1-) deuterium-6,6,7,7,8,8゜8-hebutafluorooctanedionate-(3゜5)]-europium (I[[) (Eu(fad)s) etc. Illustrated. Lewis acid is 2
I can stay.
本反応は溶媒中で行われ、用いられる溶媒としては、ジ
クロロメタン、クロロホルム、四塩化炭素、1.2−ジ
クロロエタンなどのハロゲン化炭化水素系溶媒、トルエ
ン、キシレンなどの炭化水素系溶媒、エーテル、テトラ
ヒドロフラン、ジオキサンなどのエーテル系溶媒、アセ
トニトリル、ジメチルホルムアミドなどが例示できるが
、好適には、ジクロロメタンが用いられる。This reaction is carried out in a solvent, and the solvents used include halogenated hydrocarbon solvents such as dichloromethane, chloroform, carbon tetrachloride, and 1,2-dichloroethane, hydrocarbon solvents such as toluene and xylene, ether, and tetrahydrofuran. , ether solvents such as dioxane, acetonitrile, dimethylformamide, etc., but dichloromethane is preferably used.
6本反応は、−100℃〜50℃で行われるが、四塩化
チタンなどの弱いルイス酸では一100℃〜−40℃が
好適であり、またヨウ化亜鉛などの弱いルイス酸では0
℃〜50℃が最も好ましい結果を与える。The reaction is carried out at -100°C to 50°C, but for weak Lewis acids such as titanium tetrachloride, temperatures of -100°C to -40°C are suitable, and for weak Lewis acids such as zinc iodide, the temperature is 0°C.
C to 50 C gives the most favorable results.
本反応において(S)−配置を有する2−アミノプロパ
ナール誘導体を用いた場合、(33,43)−配置を有
する4−アミノ−3−ヒドロキシペンタン酸誘導体が、
(3R,4R)−配置を有する誘導体に対して高立体選
択的に生成する。When a 2-aminopropanal derivative having an (S)-configuration is used in this reaction, a 4-amino-3-hydroxypentanoic acid derivative having a (33,43)-configuration is
It is produced with high stereoselectivity towards derivatives having the (3R,4R)-configuration.
本反応において、(S)−ロイシナール誘導体および(
S)−シクロヘキシルアラニナールm1体を一般式(1
)で表される2−アミノプロパナール誘導体として用い
た場合には、(3S。In this reaction, (S)-leucinal derivative and (
S)-cyclohexylalaninal m1 is represented by the general formula (1
) When used as a 2-aminopropanal derivative represented by (3S.
4S)−4−アミノ−3−ヒドロキシ−6−メチルへブ
タン酸誘導体および(3S、4S)−4アミノ−5−シ
クロへキシル−3−ヒドロキシペンタン酸誘導体が(3
R,43)−配置を有する誘導体に対してそれぞれ高立
体選択的(I&大94:6および95:5)に生成する
。4S)-4-amino-3-hydroxy-6-methylhebutanoic acid derivative and (3S,4S)-4amino-5-cyclohexyl-3-hydroxypentanoic acid derivative are (3
R,43)-configuration with high stereoselectivity (I & O 94:6 and 95:5), respectively.
上記の合成工程によって得られた一般式(+)で表され
る4−アミノ−3−ヒドロキシペンタン酸誘導体を、酸
性条件下、加水分解反応に付することにより4位アミノ
基と1位カルボン酸基の脱保護を同時に行い、一般式
(式中、R1は前記と同じ意味を表す)で表される医薬
品合成中間体として有用な4−アミノ−3−ヒドロキシ
ペンタン酸が得られた0本加水分解反応を(3S、4S
)−4−アミノ−3−ヒドロキシ−6−メチルへブタン
酸誘導体および(3S。The 4-amino-3-hydroxypentanoic acid derivative represented by the general formula (+) obtained by the above synthesis process is subjected to a hydrolysis reaction under acidic conditions to form an amino group at the 4-position and a carboxylic acid at the 1-position. The groups were simultaneously deprotected, and 4-amino-3-hydroxypentanoic acid, which is useful as a pharmaceutical synthesis intermediate represented by the general formula (wherein R1 represents the same meaning as above), was obtained. The decomposition reaction (3S, 4S
)-4-amino-3-hydroxy-6-methylhebutanoic acid derivative and (3S.
4S)−4−アミノ−5−シクロへキシル−3−ヒドロ
キシペンタン酸誘導体に対して行った場合には、ヒトレ
ニン阻害作用により高血圧症の治療剤として有用なアミ
ノ酸誘導体の製造中間体として用いられる光学活性(3
3,43)−4−アミノ−3−ヒドロキシ−6−メチル
へブタン酸((35,43)−スタチン〕および(3S
。When carried out on 4S)-4-amino-5-cyclohexyl-3-hydroxypentanoic acid derivatives, optical Activity (3
3,43)-4-amino-3-hydroxy-6-methylhebutanoic acid ((35,43)-statin) and (3S
.
4S)−4−アミノ−5−シクロへキシル−3−ヒドロ
キシペンタン酸[(33,4S)−シクロへキシルスタ
チン]がそれぞれ得られる。4S)-4-amino-5-cyclohexyl-3-hydroxypentanoic acid [(33,4S)-cyclohexylstatin] is obtained, respectively.
以下、本発明の内容を実施例、参考例を用いて詳細に説
明するが、本発明はこれらによって何ら限定されるもの
ではない。Hereinafter, the content of the present invention will be explained in detail using Examples and Reference Examples, but the present invention is not limited by these in any way.
参考例1
(S)−ロイシンメチルエステル239■(1,65m
mol)を無水塩化メチレン5 m lに溶解し、水冷
上炭酸カリウム228■(1,65mmol)を添加後
、クロロ炭酸イソプロピル0.23m1 (1,98
mmo l)をゆっくりと滴下した。水冷下、1時間撹
拌後、飽和*’e水を加えエーテル抽出した。抽出液は
無水硫酸ナトリウムで乾燥後、減圧上濃縮し、残渣をシ
リカゲルカラムクロマトグラフィ−(ヘキサン:酢酸エ
チル=4:1)により精製し、N−(イソプロポキシカ
ルボニル)−(S)−ロイシンメチルエステルを無色オ
イル状化合物として333■(87%)得た。Reference example 1 (S)-leucine methyl ester 239■ (1,65m
mol) in 5 ml of anhydrous methylene chloride, and after adding 228 ml (1,65 mmol) of water-cooled potassium carbonate, 0.23 ml (1,98 mol) of isopropyl chlorocarbonate was added.
mmol) was slowly added dropwise. After stirring for 1 hour under water cooling, saturated *'e water was added and extracted with ether. The extract was dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (hexane:ethyl acetate = 4:1) to obtain N-(isopropoxycarbonyl)-(S)-leucine methyl ester. 333 (87%) of the compound was obtained as a colorless oily compound.
(α)i、0 4JQ°(c 1.53. CHC
l3)’H−NMR(CDCI 3) δ:4.90
(2H,m and 5ept、J=6.2Hz)。(α)i, 0 4JQ°(c 1.53.CHC
l3)'H-NMR (CDCI 3) δ: 4.90
(2H, m and 5ept, J=6.2Hz).
4.40(IH,s+)、3.73(38,s)、1.
3 〜1.8(31),m)。4.40 (IH, s+), 3.73 (38, s), 1.
3 to 1.8 (31), m).
1.23(6)1.d、J−6,1Hz)、0.95(
6H,m)。1.23(6)1. d, J-6,1Hz), 0.95(
6H, m).
IR(CllCl3) : 3460.2970.1
730.1710.1510.1)10C1)−’MS
(m/z): 231(Mつ、 172.8G、 43
゜参考例2
N−(イソプロポキシカルボニル)−(S)−ロイシン
メチルエステル333■(0,144mmol)を無水
テトラヒドロフラン4mlに溶解し、塩化リチウム18
31g (4,32mmo l)、水素化ホウ素ナトリ
ウム163g (4,32mmol)無水エタノール6
mlを順次加え、室温下5時間攪拌した0反応液を減圧
上濃縮後、IMa!酸を加え(pH2〜3)酢酸エチル
で抽出した。抽出液は硫酸ナトリウムで乾燥後、溶媒を
減圧留去した。得られた粗成績体は、シリカゲルカラム
クロマトグラフィーにより精製して(ヘキサン:酢酸エ
チル■2 : 1) 、N−(イソプロポキシカルボニ
ル)(S)−ロイシノール292■(定量的収率)を得
た。IR(CllCl3): 3460.2970.1
730.1710.1510.1)10C1)-'MS
(m/z): 231 (M, 172.8G, 43
゜Reference Example 2 333 mmol (0,144 mmol) of N-(isopropoxycarbonyl)-(S)-leucine methyl ester was dissolved in 4 ml of anhydrous tetrahydrofuran, and 18 ml of lithium chloride was dissolved.
31g (4,32mmol), sodium borohydride 163g (4,32mmol) absolute ethanol 6
ml of IMa! Acid was added (pH 2-3) and extracted with ethyl acetate. After drying the extract over sodium sulfate, the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane:ethyl acetate 2:1) to obtain 292 N-(isopropoxycarbonyl)(S)-leucinol (quantitative yield). .
(α) i’ −30,9” (C1,05,Cll
Cl、)’If−+iMR(CDCIs) δ;4.
90(IH,5ept、J・6.2Hz)、4.70(
1)1,m)、3.65(31),m)、2.45(1
B、brs)、1.3〜2.0(3H,m)、1.23
(68,d、J=6.2Hz)、0.93(6H,d。(α) i'-30,9" (C1,05,Cll
Cl,)'If-+iMR(CDCIs) δ;4.
90 (IH, 5ept, J・6.2Hz), 4.70 (
1) 1, m), 3.65 (31), m), 2.45 (1
B, brs), 1.3-2.0 (3H, m), 1.23
(68, d, J=6.2Hz), 0.93 (6H, d.
JJ、 4Hz) 。JJ, 4Hz).
IR(CICI=) :3460,2970.1700
,1510.1)10cm−’MS(m/z): 2
04(M’+1)、 172. 130. 86.
43参考例3
N−(イソプロポキシカルボニル’I −(S)ロイシ
ノール281g (1,38mmo 1) 、トルエン
1ml、ジメチルスルホキシド1.8m l(25,4
mmo l)およびトリエチルアミン1.16m1
(1),30mmo l)の混合溶液に二酸化イオウ−
ピリジン錯塩1.321X(3,30mmo l)を加
え、室温で30分間攪拌した0反応液に氷水を加え、酢
酸エチルで抽出し、抽出液を乾燥後、溶媒を減圧留去し
た。この粗成績体は、シリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル−8=1)により精製し、
N−(イソプロポキシカルボニル)−(S)−ロイシナ
ール219ftM(79%)を無色油状物として甫た。IR(CICI=) :3460,2970.1700
, 1510.1) 10cm-'MS (m/z): 2
04(M'+1), 172. 130. 86.
43 Reference Example 3 N-(isopropoxycarbonyl'I-(S)leucinol 281g (1,38mmo 1), toluene 1ml, dimethyl sulfoxide 1.8ml (25,4
mmol) and triethylamine 1.16 ml
(1), 30 mmol) of sulfur dioxide
1.321X (3.30 mmol) of pyridine complex salt was added and stirred at room temperature for 30 minutes. Ice water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. After drying the extract, the solvent was distilled off under reduced pressure. This crude product was purified by silica gel column chromatography (hexane:ethyl acetate-8=1),
219 ftM (79%) of N-(isopropoxycarbonyl)-(S)-leucinal was discharged as a colorless oil.
(ff)3” +34.4°(CO,964,Cll
Clり’H−NMR(CDCIs) δ:9.59
(1B、s)、4.92(2H,m andsI!p
t、 J−6,2Hz) 、 4.25(ill、 w
) 、 1.3〜! 、9. (31),@) 。(ff) 3” +34.4° (CO, 964, Cll
Cl'H-NMR (CDCIs) δ: 9.59
(1B, s), 4.92 (2H, m andsI!p
t, J-6,2Hz), 4.25(ill, w
), 1.3~! ,9. (31), @).
1.24(6H,d、J−6,2Hz) 、O’、97
(61),a) 。1.24 (6H, d, J-6, 2Hz), O', 97
(61), a).
IR(CHCIs) :3460,29B0.2720
.1720. 、1710.15001380.1)1
0cm−’
MS(m/z): 172.130.86.43゜参考
例4
(S)−フェニルアラニンメチルエステル塩酸塩3.9
0 g (1i3mmo 1)を無水テトラヒドロフラ
ン20m1に懸濁し、水冷下トリエチルアミン5.5m
l (39mmo +) 、りoロ炭酸イソプロピル
2.3ml (20mmol)を加えて同温度で1時
間攪拌した0反応液を減圧上濃縮し残渣に酢酸エチルを
加え、1M塩酸、飽和食塩水、飽和重曹水、および飽和
食塩水で順次洗浄した。無水硫酸マグネシウム上で乾燥
後、減圧下に濃縮し、残渣をカラムクロマトグラフィー
(シリカゲル、ヘキサン−酢酸エチル10:l)で精製
し、白色固体のN−(イソプロポキシカルボニル”I
−(S)−フェニルアラニンメチルエステル4.35g
(91%)を得た。IR (CHCIs): 3460, 29B0.2720
.. 1720. , 1710.15001380.1)1
0cm-' MS (m/z): 172.130.86.43° Reference Example 4 (S)-Phenylalanine methyl ester hydrochloride 3.9
0 g (1i3 mmo 1) was suspended in 20 ml of anhydrous tetrahydrofuran, and 5.5 ml of triethylamine was added under water cooling.
1 (39 mmol +) and 2.3 ml (20 mmol) of isopropyl carbonate were added and stirred at the same temperature for 1 hour. The reaction solution was concentrated under reduced pressure, and ethyl acetate was added to the residue. It was washed successively with a sodium bicarbonate solution and a saturated saline solution. After drying over anhydrous magnesium sulfate, it was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, hexane-ethyl acetate 10:l) to obtain a white solid N-(isopropoxycarbonyl"I").
-(S)-Phenylalanine methyl ester 4.35g
(91%).
136〜37℃。136-37℃.
lINMR(CDCI*) δ:1.21([i)I
、d、J−6Hz、CIIMer)。lINMR(CDCI*) δ:1.21([i)I
, d, J-6Hz, CIIMer).
3.1)(21),d、J−6Hz、r’l+c1)g
)、3.72(31),S、OMe)4.50〜5.2
0(2JI、m、CtII and NH)、4.92
(LH。3.1) (21), d, J-6Hz, r'l+c1)g
), 3.72 (31), S, OMe) 4.50-5.2
0 (2JI, m, CtII and NH), 4.92
(LH.
quir!tet、 J−6Hz、CHMst)+7
−04〜7.48(5H1a+Ph) 。Quir! tet, J-6Hz, CHMst)+7
-04 to 7.48 (5H1a+Ph).
TR(KBr):1740.1685cn−’MS(m
/z): 266 (CM”++1 ’ )、20
6,162.131,120゜参考例5
N−(イソプロポキシカルボニル)−(S)フェニルア
ラニンメチルエステル2.52g (9,5mmol)
を無水テトラヒドロフランに溶解し、塩化リチウム1.
22g (29mmol)、水素化ホウ素ナトリウム1
.09 g (’、! 9mmo り 、無水エタノ
ール25m1を順次加え室温で16.5時間攪拌した0
反応液を減圧上濃縮し、残渣に1M塩酸を加えてp +
+ 2〜3に!1!整した後、酢酸エチルで抽出した。TR(KBr):1740.1685cn-'MS(m
/z): 266 (CM"++1'), 20
6,162.131,120゜Reference Example 5 N-(isopropoxycarbonyl)-(S)phenylalanine methyl ester 2.52g (9.5mmol)
was dissolved in anhydrous tetrahydrofuran, and lithium chloride 1.
22g (29mmol), sodium borohydride 1
.. 09 g (',! 9 mmol) and 25 ml of absolute ethanol were sequentially added and stirred at room temperature for 16.5 hours.
The reaction solution was concentrated under reduced pressure, and 1M hydrochloric acid was added to the residue to give p +
+2~3! 1! After adjusting, the mixture was extracted with ethyl acetate.
抽出液を水、飽和食塩水で順次洗浄し、無水硫酸ナトリ
ウム上で乾燥後、減圧下に濃縮した。残渣をカラムクロ
マトグラフィー(シリカゲル、ヘキサン−酢酸エチル5
; 1−3 : 1)で精製し、白色固体9N−(イ
ソプロポキシカルボニル)−(S)−フェニルアラニノ
ール2.21g(98%)を得た。The extract was washed successively with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, hexane-ethyl acetate 5
; 1-3: 1) to obtain 2.21 g (98%) of white solid 9N-(isopropoxycarbonyl)-(S)-phenylalaninol.
sap 78−81℃。sap 78-81℃.
NMR(CDC1z) : δ1.21(6H,d、
J=6Hz、C)1Met)、1.96〜2.30(I
H,m、OR)、2.88(2H,d、J−7Hz、p
hCHg)、3.44〜4.IG(3)1.m、Ct−
Hand CHxOH)、4.65〜5.13(1)1
.s、NH)、4.92(1)1.quintet J
−61)z、CHMex)+7.05〜7.47(5H
,a+、Ph)。NMR (CDC1z): δ1.21 (6H, d,
J=6Hz, C)1Met), 1.96-2.30(I
H, m, OR), 2.88 (2H, d, J-7Hz, p
hCHg), 3.44-4. IG(3)1. m, Ct-
Hand CHxOH), 4.65-5.13(1)1
.. s, NH), 4.92(1)1. quintet J
-61)z,CHMex)+7.05~7.47(5H
, a+, Ph).
+R(KBr):1690cm−’
MS(m/z) :237(M’) 、206.146
.120゜元素分析値: C+sH+vNOsとして計
′lLw: C65,80X; H8,07!; N
5.90!。+R (KBr): 1690 cm-' MS (m/z): 237 (M'), 206.146
.. 120° elemental analysis value: Total as C+sH+vNOs: C65,80X; H8,07! ;N
5.90! .
分析値: C65,99χ、 H8,03χ; !15
.81χ。Analysis values: C65,99χ, H8,03χ; ! 15
.. 81χ.
参考例6
N−(イソプロポキシカルボニル)−(S)フェニルア
ラニノール2.05 g (8,6mmo l)をメタ
ノール6mlに熔解し、ロジウノ・−アルミナ触媒40
3■、酢酸0.6mlを加え、水素雰囲気下(4気圧)
、室温で5時間攪拌した。触媒を除去した後、溶媒を減
圧上濃縮し、残渣をカラムクロマトグラフィー(シリカ
ゲル、ヘキサン−酢酸エチル5:l)で精製し、無色オ
イル状のN(イソプロポキシカルボニル)−(S)−シ
クロへキシルアラニノール2.09 g (100%)
を得た。Reference Example 6 2.05 g (8.6 mmol) of N-(isopropoxycarbonyl)-(S)phenylalaninol was dissolved in 6 ml of methanol, and 40 g of rhodiuno-alumina catalyst was dissolved.
3) Add 0.6 ml of acetic acid and under hydrogen atmosphere (4 atm)
and stirred at room temperature for 5 hours. After removing the catalyst, the solvent was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, hexane-ethyl acetate 5:l) to give N(isopropoxycarbonyl)-(S)-cyclo as a colorless oil. Xylalaninol 2.09 g (100%)
I got it.
NMR(CDCI s) : δ1.23(61),
d、J=6)1z、CIIMez) 、0.71〜2.
13(131),s、cycloba*yり 、3.3
6〜4.02(3H。NMR (CDCIs): δ1.23 (61),
d, J=6)1z, CIIMez), 0.71-2.
13(131), s, cycloba*yri, 3.3
6-4.02 (3H.
m、C1−Hand CHtOH)、4.51〜5.1
5(IH,m、N旧4.93(IH,qulntet
J=6Hz、CHMez)。m, C1-Hand CHtOH), 4.51-5.1
5 (IH, m, N old 4.93 (IH, quntet)
J=6Hz, CHMez).
1R(neat):1690 am−’MS(m/z)
:244(CM+1) ’ 212,170.12
6元素分析値i C+!HtsNO! ・0.IHI
Oとして計算値: C63,69χ、 H10,36X
: N 5.71!。1R (neat): 1690 am-'MS (m/z)
:244(CM+1)' 212,170.12
6 element analysis value i C+! HtsNO!・0. IHI
Calculated value as O: C63,69χ, H10,36X
: N 5.71! .
分析+!!; C63,56χi H10,39χ、
N 5.75χ。Analysis+! ! ; C63,56χi H10,39χ,
N 5.75χ.
参考例7
N−(イソプロポキシカルボニル)−(S)シクロへキ
シルアラニノール138■(0,57mmol)、無水
トルエン0.33m1、無水ジメチルスルホキシド0.
67m1 (9,4mmo l)、およびトリエチル
アミン0.43m l(3,1mmo l)の混合物に
三酸化イオウ−ピリジン錯塩491nr(3,1mmo
l)を加え室温で20分間撹拌した。Reference Example 7 N-(isopropoxycarbonyl)-(S)cyclohexylalaninol 138 ml (0.57 mmol), anhydrous toluene 0.33 ml, anhydrous dimethyl sulfoxide 0.
Sulfur trioxide-pyridine complex salt 491nr (3.1mmol) was added to a mixture of 67ml (9.4mmol) and triethylamine 0.43ml (3.1mmol).
1) was added and stirred at room temperature for 20 minutes.
反応液に氷水を加え、酢酸エチルで抽出した。抽出液を
水、飽和食塩水で91)次洗浄し、無水硫酸ナトリウム
で乾燥後、減圧下に濃縮した。残渣をカラムクロマトグ
ラフィー(シリカゲル、ヘキサン−酢酸エーテル10:
1−5:1)で精製し、無色オイル状のN−(イソプロ
ポキシカルボニル)−(S)−シクロヘキシルアラニナ
ール107■(78?()を得た。Ice water was added to the reaction solution, and the mixture was extracted with ethyl acetate. The extract was washed with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was subjected to column chromatography (silica gel, hexane-acetic ether 10:
1-5:1) to obtain N-(isopropoxycarbonyl)-(S)-cyclohexylalaninal 107 ? (78?()) in the form of a colorless oil.
(α)4’ +26.6°(C=0.939. Cl
lCl、) 。(α)4' +26.6° (C=0.939.Cl
lCl,).
NMR(CDCI 、) : δ0.60〜2.06
(131),vcycloheyyl) 。NMR (CDCI, ): δ0.60-2.06
(131), vcycloheyyl).
1.23(6tl、d、J=7Hz、cHMet>、4
.03〜4.43(IH。1.23 (6tl, d, J=7Hz, cHMet>, 4
.. 03-4.43 (IH.
m、Cx−H)、4.93(IH,q、J−6Hz、C
)IMez)、5.20〜5.52(LH,m、NH)
、9.56(LH,s、CHO)。m, Cx-H), 4.93 (IH, q, J-6Hz, C
) IMez), 5.20 to 5.52 (LH, m, NH)
, 9.56 (LH,s, CHO).
IR(neat):1730.1690 cm−’MS
(m/z):242 (M+1) ’、212,17
0,126゜実施例1
H
N−(−(ソブロボキシカルボニル)−(S)ロイシナ
ール28.9w (0,144mmo 1)とモレキュ
ラシーブ4A(5w)にアルゴン気流下、0−メチル−
〇−)リメチルシリルケテンアセタール63,0曙(0
,431n口に101)の塩化メチレン溶液2mlを加
え、−78℃に冷却後、三フッ素化ホウ素・エーテル錯
体(IM塩化メナレン溶液)O,17m1をゆっくり滴
下した0反応液を1時間攪拌した後、飽和重曹水を加え
酢酸エチルで抽出し、1M塩酸で洗浄、乾燥後、微圧下
溶媒を留去した。この粗成績体はシリカゲルカラムク【
171−グラフィー(ヘキサン:酢酸エチル−4,1)
で精製し、(3S、4S)−3−ヒドロキシ−6−メチ
ル−4−((N−イソプロポキシカルボニル)アミン〕
へブタン酸メチル19.4■とその(3R,43)一体
6.54および両者の混合物2.6躍(全収率72%)
を得た。(33,43)−体と(3R,43)一体との
生成比は、ガスクロマトグラフィー (5XSi1ar
lOC,190℃)から80 : 20と決定した。IR(neat): 1730.1690 cm-'MS
(m/z): 242 (M+1)', 212, 17
0,126° Example 1 H N-(-(sobroboxycarbonyl)-(S)leucinal 28.9w (0,144mmo 1) and molecular sieve 4A (5w) under argon flow, 0-methyl-
〇-) Limethylsilylketene acetal 63,0 Akebono (0
, 2 ml of the methylene chloride solution of 101) was added to the opening of 431n, and after cooling to -78°C, 17 ml of boron trifluoride/ether complex (IM menalene chloride solution) O was slowly added dropwise.The reaction solution was stirred for 1 hour. After adding saturated sodium bicarbonate solution and extracting with ethyl acetate, washing with 1M hydrochloric acid and drying, the solvent was distilled off under slight pressure. This crude material is a silica gel column [
171-Graphy (hexane:ethyl acetate-4,1)
(3S,4S)-3-hydroxy-6-methyl-4-((N-isopropoxycarbonyl)amine]
Methyl hebutanoate: 19.4 kg, its (3R,43) monomer, 6.54 kg, and a mixture of both: 2.6 kg (total yield 72%)
I got it. The production ratio of (33,43)-isomer and (3R,43)-isomer is determined by gas chromatography (5XSi1ar
The ratio was determined to be 80:20 from 1OC, 190°C).
(3S、4S)−木
〔α)3’−43,2°(C1,0?、Cl1C13)
’It−NMR(CDCh)δ : 4.98(Hl、
st+pt、J=6.21)z)。(3S, 4S) - Tree [α) 3' - 43,2° (C1,0?, Cl1C13)
'It-NMR (CDCh) δ: 4.98 (Hl,
st+pt, J=6.21)z).
4.82(ill、 brd、 J=9.71)z)
、 4.03(1B、 brs) 。4.82(ill,brd,J=9.71)z)
, 4.03 (1B, brs).
3.72(3H,s)、3.67(IH,m)、3.3
0(III、brs)2.53(2H,m)、1.66
(III、鵬)、1.54(IH,w)。3.72 (3H, s), 3.67 (IH, m), 3.3
0 (III, brs) 2.53 (2H, m), 1.66
(III, Peng), 1.54 (IH, w).
1.35(ltl、m)、1.23(6)1.d、J=
6.2Hz)、0.93(6H,m)。1.35 (ltl, m), 1.23 (6) 1. d, J=
6.2Hz), 0.93 (6H, m).
:R(CtlCIx) :3470.2980.1?1
0.1505.1)10 C1)−’MS(IS/z)
:276.216.1721308643゜(3R,
4S)一体
〔α〕b0−29.8°CC,0,650,C)IC1
,)l1p63〜65℃(fro@EtxO−hexa
ne)。:R(CtlCIx) :3470.2980.1?1
0.1505.1)10 C1)-'MS(IS/z)
:276.216.1721308643゜(3R,
4S) Integral [α] b0-29.8°CC, 0,650, C) IC1
,)l1p63~65℃(fro@EtxO-hexa
ne).
’H−NM[1(CDCIs) δ : 4.8
9(IH,5ept、J−6,1Hz)。'H-NM[1(CDCIs) δ: 4.8
9 (IH, 5ept, J-6, 1Hz).
4.62(1)1. brd、 J−7,8)1z)
、 4.02(Ill、 brs) 。4.62(1)1. brd, J-7,8)1z)
, 4.02 (Ill, brs).
3.71(4H,s and s)、3.35(L
H,brs)、2.50(2H,m)、1.68(1)
(、糟)、1.34(2H,m)、1.23(6N。3.71 (4H, s and s), 3.35 (L
H, brs), 2.50 (2H, m), 1.68 (1)
(, 糟), 1.34 (2H, m), 1.23 (6N.
d、 J=6.1Hz) 、 0.94 (6H,d、
J=6.5Hz) 。d, J=6.1Hz), 0.94 (6H,d,
J=6.5Hz).
IR(CHCI 、) :3460.2970.1?1
0.1505.1)10 値−1MS(m/z) :
316,256,212,170,126,71,43
゜実施例2
0i(
N−(イソプロポキシカルボニル)−(S)ロイシナー
ル8.7N (0,0433mmo I)とモレキュラ
シーブ4A 4■にアルゴン気流下、Oメチル−〇−
トリメチルシリルケテンアセクール19mg (0,1
3mmo I)の塩化メナレン溶液0.5mlを加え、
−78℃に冷却後、四塩化チタン(1M塩化メチレン溶
液) 0.065 m lをゆっくり滴下した0反応液
を1時間攪拌したのら、飽和重曹水を少量加え、セライ
ト濾過した。Ill液は減圧上溶媒留去し得られた残渣
は、シリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:l)により精製して、(3S、43)
−3ヒドロキシ−6−メチル−4−((N−イソプロポ
キシカルボニル)アミン〕ヘプタン酸メチルおよびその
(3R,4S)一体の混合物10.6■(89%)を得
た。(3S、4S)一体と(3R24S)一体との生成
比はガスクロマグラフイー(5χ5ilarlOC,1
90℃)から95:5と決定した。IR(CHCI,) :3460.2970.1?1
0.1505.1) 10 Value - 1MS (m/z):
316, 256, 212, 170, 126, 71, 43
゜Example 2 0i (N-(isopropoxycarbonyl)-(S) leucinal 8.7N (0,0433 mmo I) and molecular sieve 4A 4■ under an argon atmosphere, O methyl-〇-
Trimethylsilylketene acecool 19mg (0,1
Add 0.5 ml of 3 mmol I) menalene chloride solution,
After cooling to -78°C, 0.065 ml of titanium tetrachloride (1M methylene chloride solution) was slowly added dropwise to the reaction mixture, which was stirred for 1 hour. A small amount of saturated aqueous sodium bicarbonate was added and filtered through Celite. The solvent of the Ill solution was distilled off under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (hexane:
Purified by ethyl acetate = 4:l) to give (3S, 43)
10.6 μm (89%) of a mixture of methyl-3hydroxy-6-methyl-4-((N-isopropoxycarbonyl)amine)heptanoate and its (3R,4S) were obtained.(3S,4S) The production ratio of monolithic and (3R24S) monolithic is determined by gas chromatography (5χ5ilarlOC, 1
90°C) to 95:5.
実施例3〜7
実施例3〜5については実施例2と同様に、また、実施
例6〜7については実施例1と同様に行イTable
1の結果を得た。ただし、ルイス酸、溶媒、および反応
温度はそれぞれ表記の条件を用いた。Examples 3 to 7 Examples 3 to 5 are set in the same manner as in Example 2, and Examples 6 to 7 are set in the same manner as in Example 1.
1 result was obtained. However, the Lewis acid, solvent, and reaction temperature used the conditions indicated.
実施例8
0H
N−(イソプロポキシカルボニル)−(S)−シクロへ
キシルアラニナール61.0■(0,253mmol)
とモレキュラシープ4A(30g)にアンボン気流下、
0−メチル−〇−)リメチルシリルケテンアセクール1
)0 w(0,759mm o 1 )の塩化メチレン
溶液3mlを加え、−78°Cに冷却後、四塩化チタン
(1M塩化メチレン溶液)0.25rnlをゆっくり滴
下した0反応液を1時間撹拌した後、飽和重曹水を少量
加え、セライト濾過した。濾液は減圧下に留去し、残渣
をシリカゲルカラムクロマトグラフィー(ヘキサン:酢
酸エチル−4:l)により精製して、原料16.7■(
27%)、(33,43)−5−シクロへキシル−3−
ヒドロキシ−4−((N−イソプロポキシカルボニル)
アミノ〕ペンタン酸メチル50.0■(63%)、その
(3R,43)一体6.0■(7,5%)および両者の
混合物2.8■を得た。Example 8 0H N-(isopropoxycarbonyl)-(S)-cyclohexylalaninal 61.0■ (0,253 mmol)
and Molecular Sheep 4A (30g) under Ambon air flow,
0-Methyl-〇-)limethylsilylketene acecool 1
) 0 w (0,759 mm o 1) in methylene chloride solution was added, and after cooling to -78°C, 0.25 rnl of titanium tetrachloride (1M methylene chloride solution) was slowly added dropwise. The reaction solution was stirred for 1 hour. After that, a small amount of saturated sodium bicarbonate solution was added, and the mixture was filtered through Celite. The filtrate was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (hexane:ethyl acetate-4:l) to obtain 16.7μ of the raw material (
27%), (33,43)-5-cyclohexyl-3-
Hydroxy-4-((N-isopropoxycarbonyl)
50.0 µm (63%) of methyl amino]pentanoate, 6.0 µm (7.5%) of its (3R,43) body, and 2.8 µm of a mixture of both were obtained.
(33,4S)一体と(3R,43)一体との生成比は
ガスクロマトグラフィー(5χ5ilar l0C19
0℃)から96:4と決定した。The production ratio of (33,4S) and (3R,43) was determined by gas chromatography (5χ5ilar l0C19
0°C) to 96:4.
(3S、 4S)一体
(α)p −36,6°(C1,1),cHcI3)H
−NMR(CDC1z)δ : 4.88(1)1,5
ept、J−6,2Hz)4.77(LH,brd、J
=9.8Hz)、4.02(IH,brd、J−6,7
Hz)、3.71(3)1.s)、3.69(IH,m
)、3.24(IH。(3S, 4S) integral (α)p −36,6° (C1,1), cHcI3)H
-NMR (CDC1z) δ: 4.88 (1) 1,5
ept, J-6, 2Hz) 4.77 (LH, brd, J
=9.8Hz), 4.02(IH,brd,J-6,7
Hz), 3.71(3)1. s), 3.69 (IH, m
), 3.24 (IH.
brs)、2.52(2H,m)、1.82(IH,b
rs)、1.66(4H。brs), 2.52 (2H, m), 1.82 (IH, b
rs), 1.66 (4H.
s)、1.3〜1.6(2H,m)、1.23(6H,
d、J=6.2Hz)。s), 1.3-1.6 (2H, m), 1.23 (6H,
d, J=6.2Hz).
1.1〜1.3(2H,1)1)、0.8〜1.1(2
)1.m)。1.1-1.3 (2H, 1) 1), 0.8-1.1 (2
)1. m).
IR(CHCIs) :3470.2940,2870
.1?10.1505.1440゜1)10cm−’
MS(s/z):316,256,212,170,1
26,100.43゜(3R,43)一体
〔α〕 2・ −30,8” (CO,510,CHC
l5)mp 73〜74℃Cfrom hexane)
。IR (CHCIs): 3470.2940, 2870
.. 1?10.1505.1440゜1) 10cm-' MS (s/z): 316,256,212,170,1
26,100.43゜(3R,43) integral [α] 2. -30,8” (CO,510,CHC
l5)mp 73-74℃Cfrom hexane)
.
’H−NMR(CDCIs)δ : 4.89(IH,
5ept、J−6,01lz)。'H-NMR (CDCIs) δ: 4.89 (IH,
5ept, J-6,01lz).
4.60(IH,brd、J−7,7Hz)、4.02
(IH,W)、3.77(1)1.m)、3.71(3
H,s)、3.38(1M、brs)、2.48(2H
,m)+1.83(IH,brd、J−13,0Hz)
、1.53〜1.76(4H,■)、1.1〜1.5(
5H,m)、1.23(6H,d。4.60 (IH,brd,J-7,7Hz), 4.02
(IH, W), 3.77(1)1. m), 3.71 (3
H, s), 3.38 (1M, brs), 2.48 (2H
, m) +1.83 (IH,brd,J-13,0Hz)
, 1.53-1.76 (4H, ■), 1.1-1.5 (
5H, m), 1.23 (6H, d.
J−6,0Hz)、0.7〜1.1(2H,m)。J-6,0Hz), 0.7-1.1 (2H, m).
rR(CHCI 、) :3690.3460,293
0.2860.1710.1500゜1430.1)1
0 cm−’
MS(II/Z) :276.216,172,13
0,86,43゜参考例8
H
H
(33,43)−3−ヒドロキシ−6−メチルを加えて
13時間100℃で加熱した0反応液を減圧下、溶媒留
去後、残渣をイオン変換カラムクロマトグラフ 4−
(Dowex AG50W−X2.pH51)31液(
1Mピリジン−酢酸)〕により精製して(3S。rR(CHCI,) :3690.3460,293
0.2860.1710.1500゜1430.1)1
0 cm-' MS (II/Z): 276.216, 172, 13
0,86,43゜Reference Example 8 H H (33,43)-3-hydroxy-6-methyl was added and the 0 reaction solution was heated at 100°C for 13 hours, and the solvent was distilled off under reduced pressure, and the residue was ion-converted. Column chromatograph 4-
(Dowex AG50W-X2.pH51) 31 liquid (
1M pyridine-acetic acid)] (3S.
純品は水−エタノールから再結晶して500■を得た。The pure product was recrystallized from water-ethanol to obtain 500μ.
〔α〕6・ −20,4°(CO,501,H*0)Q
202〜205℃
文献値(M、Klnoshita et al、、Bu
ll、Chem、Soc。[α]6・-20,4°(CO,501,H*0)Q
202-205°C Literature value (M, Klnoshita et al, Bu
ll, Chem, Soc.
Jpn、、旦、 570 (1975) ) 。Jpn,, Dan, 570 (1975)).
〔α)ダ −20責C0,64+watsr)MP 2
01 〜203 ℃(decomp) 。[α) Da -20 Responsibility C0,64+watsr) MP 2
01-203°C (decomp).
’H−NMR(D*Q) δ : 4.10(1
)(、論)、3.30(lit、輸)2.53(III
、dd、J−5,1and 15Hz)、2.48(1
8゜dd、J−7,0and 15Hz)、0.94(
6H,d、J−5,7)1z)。'H-NMR(D*Q) δ: 4.10(1
) (, theory), 3.30 (lit, import) 2.53 (III
, dd, J-5, 1 and 15Hz), 2.48 (1
8゜dd, J-7,0and 15Hz), 0.94(
6H, d, J-5, 7) 1z).
1.2〜1.9(3H))。1.2-1.9 (3H)).
IR(KBr) :3440.3220.2970.2
890.1600.1550.1510゜1430.1
390,1)70.T20備1MS(m/z) +1
76(M’+1)、172,157,140,1)8,
100゜86、40.30゜
参考例9
OH
OH
(33,43)−5−シクロへキシル−3−ヒドロキシ
−4
((N−イソプロボキシ力ルボニ
6NN塩出1を加え、8時間100℃で加熱した0反応
液を減圧上留去後、残渣をイオン交換カーフ ム/)
rl ?トゲラフイー (Dowex AG501)−
X2.pHSll衡液(1Mピリジン−酢酸)により精
製して、純品は、1M塩酸に熔解後、LM NaOH水
t8液でpH5〜6に調節し、析出する結晶を濾取乾燥
して得た。IR(KBr) :3440.3220.2970.2
890.1600.1550.1510°1430.1
390,1)70. T20 1MS (m/z) +1
76 (M'+1), 172, 157, 140, 1) 8,
100゜86, 40.30゜Reference Example 9 OH OH (33,43)-5-cyclohexyl-3-hydroxy-4 ((N-isoproboxylic carbonyl 6NN salt 1 was added and heated at 100°C for 8 hours. After distilling off the 0 reaction solution under reduced pressure, the residue was ion-exchanged.
rl? Togelafie (Dowex AG501)-
X2. Purification was performed using a pHSll equilibrium solution (1M pyridine-acetic acid), and a pure product was obtained by dissolving in 1M hydrochloric acid, adjusting the pH to 5 to 6 with LM NaOH aqueous solution t8, and filtering and drying the precipitated crystals.
〔α〕ら・ −25,3責C0,435,1M IIC
I)膳p 213〜216 ℃
文献値()1.Yanaglsawa et al、c
hem、Lett、、687(1989) 。[α] et al. -25,3 Responsibility C0,435,1M IIC
I) Meal p 213-216°C Literature value ()1. Yanaglsawa et al., c.
hem, Lett, 687 (1989).
@p 230〜231 ℃(dec、)(&)3 −2
6.2° (C1,0、It−1HC,1)處H−N?
IR([1よ0)δ : 4.00(III、■)、3
35(IH,m)。@p 230~231℃(dec,)(&)3 -2
6.2° (C1,0, It-1HC,1) 處H-N?
IR ([1 to 0) δ: 4.00 (III, ■), 3
35 (IH, m).
225(2H))、0.8 〜2.0(13H,鑓)。225 (2H)), 0.8 to 2.0 (13H, spear).
IR(KBr):3430,3220,2950.28
B0,1610.1550,1510゜1440.13
85,1335.1)15,1070,1035.98
0゜885cm−’IR (KBr): 3430, 3220, 2950.28
B0,1610.1550,1510°1440.13
85,1335.1) 15,1070,1035.98
0°885cm-'
Claims (3)
キル基、炭素数5〜8の置換もしくは無置換のシクロア
ルキル基を表し、また、R^2はアミノ基の保護基を表
す)で表される2−アミノプロパナール誘導体を、一般
式 ▲数式、化学式、表等があります▼ (式中、R^3、R^4、R^5、R^6は各々独立に
、炭素数1〜4の直鎖もしくは分枝アルキル基または置
換もしくは無置換アリール基を表す)で表されるケテン
シリルアセタールとルイス酸存在下反応させることを特
徴とする、一般式 ▲数式、化学式、表等があります▼ (式中、R^1、R^2およびR^3は前記と同じ意味
を表す)で表される4−アミノ−3−ヒドロキシペンタ
ン酸誘導体の製造方法。(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, R^1 is a straight chain or branched alkyl group having 1 to 4 carbon atoms, or a substituted or unsubstituted cycloalkyl group having 5 to 8 carbon atoms. 2-aminopropanal derivatives represented by the general formula ▲ mathematical formulas, chemical formulas, tables, etc. ▼ (in the formula, R^3, R^4, R^5, R^6 each independently represent a straight chain or branched alkyl group having 1 to 4 carbon atoms or a substituted or unsubstituted aryl group) and a Lewis acid present. There are general formulas ▲mathematical formulas, chemical formulas, tables, etc.▼ (in the formula, R^1, R^2 and R^3 represent the same meanings as above), which are characterized by the following reaction. A method for producing an amino-3-hydroxypentanoic acid derivative.
S)−配置である請求項(1)記載の4−アミノ−3−
ヒドロキシペンタン酸誘導体の製造方法。(2) The asymmetric carbon at the 3rd position is (S)-configured, and the asymmetric carbon at the 4th position is (
4-amino-3- according to claim (1), which has the S)-configuration.
A method for producing a hydroxypentanoic acid derivative.
である請求項(2)記載の4−アミノ−3−ヒドロキシ
ペンタン酸誘導体の製造方法。(3) The method for producing a 4-amino-3-hydroxypentanoic acid derivative according to claim (2), wherein R^1 is an isopropyl group or a cyclohexyl group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1259992A JPH0830049B2 (en) | 1989-10-06 | 1989-10-06 | Process for producing 4-amino-3-hydroxypentanoic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1259992A JPH0830049B2 (en) | 1989-10-06 | 1989-10-06 | Process for producing 4-amino-3-hydroxypentanoic acid derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03123765A true JPH03123765A (en) | 1991-05-27 |
JPH0830049B2 JPH0830049B2 (en) | 1996-03-27 |
Family
ID=17341786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1259992A Expired - Lifetime JPH0830049B2 (en) | 1989-10-06 | 1989-10-06 | Process for producing 4-amino-3-hydroxypentanoic acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0830049B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074795A1 (en) * | 2000-04-03 | 2001-10-11 | Ihara Chemical Industry Co., Ltd. | Process for preparing amic acid esters |
-
1989
- 1989-10-06 JP JP1259992A patent/JPH0830049B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074795A1 (en) * | 2000-04-03 | 2001-10-11 | Ihara Chemical Industry Co., Ltd. | Process for preparing amic acid esters |
US6576765B2 (en) | 2000-04-03 | 2003-06-10 | Ihara Chemical Industry Co., Ltd. | Process for preparing amic acid esters |
Also Published As
Publication number | Publication date |
---|---|
JPH0830049B2 (en) | 1996-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jouin et al. | Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid | |
JP2691442B2 (en) | Novel proline derivative | |
Yakura et al. | Synthesis of an immunomodulator (+)-conagenin and its analogs | |
CN106699604B (en) | One seed sand library is than bent and its intermediate preparation method | |
KR100209105B1 (en) | Aminobutanol derivative and process for the preparation of 3-pyrrolidinol from the same | |
JPH03123765A (en) | Production of 4-amino-3-hydroxypentanoic acid derivative | |
US4978759A (en) | Process for the stereospecific synthesis of optically pure 4-amino-3-hydroxycarboxylic acid derivatives | |
FR2710066A1 (en) | Derivatives of 1- [2-amino-5- [1- (triphenylmethyl-1H-imidazol-4-yl] -1-oxopentyl] piperidine, their preparation and their use as synthesis intermediates. | |
DK172006B1 (en) | Process for the Synthesis of Optically Active Amino Acids | |
US6610855B2 (en) | Synthesis of 3-amino-3-aryl propanoates | |
FR2566410A1 (en) | New diaminopimelic acid derivatives, a process for preparing them and their therapeutic application | |
KR950009364B1 (en) | Process for preparing optical active 2-oxoimidazolodone derivatives | |
EP0643046A1 (en) | 1,2,3,4-Tetrahydrochinolin-8-sulfonic acid and its chlorides as intermediates | |
JPH0217165A (en) | (2s,3r)-3-amino-2-acyloxy-4-phenylbutyronitrile derivative and production thereof | |
JP2524814B2 (en) | Method for producing α-hydroxy-β-amino acid | |
JP2825608B2 (en) | Optically active threo-3-amino-2-hydroxypentanoic acid and process for producing the same | |
US5959141A (en) | 1-amino-2-hydroxycycloalkanecarboxylic acid derivatives | |
FR2710067A1 (en) | Process for the preparation of 2-amino-5-(1H-imidazol-4-yl)-1-oxopentylpiperidine | |
SU1556540A3 (en) | Method of producing derivatives of thiazolidine dion or their salts with alkali metals | |
JPH0789933A (en) | Production of optically active indoline derivative and intermediate thereof | |
JPH0819071B2 (en) | 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same | |
JPH03141253A (en) | Preparation of monobactemes and their intermediate products | |
JP2756135B2 (en) | Method for producing muramyl tripeptide derivative | |
KR100684081B1 (en) | Preparation of optically active 3,4-dihydrobenzoxazine derivative | |
JPH072763A (en) | N-substituted 2-azetidinone |